serw-MX  [xml]  
 


    
 DeCS Categories

D03 Heterocyclic Compounds .
D03.383 Heterocyclic Compounds, 1-Ring .
D03.383.188 Dioxanes .
D03.383.188.712 Spectinomycin .
D03.633 Heterocyclic Compounds, Fused-Ring .
D03.633.300 Heterocyclic Compounds, 3-Ring .
D03.633.300.835 Spectinomycin .
D09 Carbohydrates .
D09.408 Glycosides .
D09.408.051 Aminoglycosides .
D09.408.051.836 Spectinomycin .
D12 Amino Acids, Peptides, and Proteins .
D12.776 Proteins .
D12.776.395 Glycoproteins .
D12.776.395.550 Membrane Glycoproteins .
D12.776.395.550.448 GPI-Linked Proteins .
D12.776.395.550.448.600 Prion Proteins .
D12.776.543 Membrane Proteins .
D12.776.543.484 Lipid-Linked Proteins .
D12.776.543.484.500 GPI-Linked Proteins .
D12.776.543.484.500.625 Prion Proteins .
D12.776.543.550 Membrane Glycoproteins .
D12.776.543.550.418 GPI-Linked Proteins .
D12.776.543.550.418.600 Prion Proteins .
D12.776.785 Prions .
D12.776.785.340 Prion Proteins .
E05 Investigative Techniques .
E05.318 Epidemiologic Methods .
E05.318.760 Epidemiologic Study Characteristics .
E05.318.760.500 Epidemiologic Studies .
E05.318.760.500.750 Cohort Studies .
E05.318.760.500.750.625 Prospective Studies .
F02 Psychological Phenomena .
F02.463 Mental Processes .
F02.463.425 Learning .
F02.463.425.540 Memory .
F02.463.425.540.254 Memory, Episodic .
N03 Health Care Economics and Organizations .
N03.219 Economics .
N03.219.151 Costs and Cost Analysis .
N03.219.521 Financing, Organized .
N03.219.521.710 Insurance, Health, Reimbursement .
N03.219.521.710.305 Reimbursement Mechanisms .
N03.219.521.710.305.200 Prospective Payment System .
N05 Health Care Quality, Access, and Evaluation .
N05.715 Quality of Health Care .
N05.715.360 Health Care Evaluation Mechanisms .
N05.715.360.775 Epidemiologic Study Characteristics .
N05.715.360.775.175 Epidemiologic Studies .
N05.715.360.775.175.250 Cohort Studies .
N05.715.360.775.175.250.630 Prospective Studies .
N06 Environment and Public Health .
N06.850 Public Health .
N06.850.520 Epidemiologic Methods .
N06.850.520.450 Epidemiologic Study Characteristics .
N06.850.520.450.500 Epidemiologic Studies .
N06.850.520.450.500.750 Cohort Studies .
N06.850.520.450.500.750.650 Prospective Studies .
SP4 Environmental Health .
SP4.051 General Aspects .
SP4.051.497 Costs and Cost Analysis .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Prospective Payment System .
Adjustment, Discretionary .
Adjustment Factor, Discretionary .
Adjustment Factors, Discretionary .
Adjustments, Discretionary .
Discretionary Adjustment .
Discretionary Adjustment Factors .
Discretionary Adjustments .
Factor, Discretionary Adjustment .
Factors, Discretionary Adjustment .
Payment System, Prospective .
Payment Systems, Prospective .
Pricing, Prospective .
Prospective Payment Systems .
Prospective Reimbursements .
Reimbursements, Prospective .
System, Prospective Payment .
Systems, Prospective Payment .
Prospective Reimbursement .
Reimbursement, Prospective .
Discretionary Adjustment Factor .
Prospective Pricing .
A system wherein reimbursement rates are set, for a given period of time, prior to the circumstances giving rise to actual reimbursement claims. .
1.00
 
Costs and Cost Analysis .
Analysis, Cost .
Cost 2626 .
Cost Analysis .
Cost Comparison .
Cost Measures .
Cost-Minimization Analysis .
Costs and Cost Analyses .
Costs, Cost Analysis .
Pricing .
Analyses, Cost .
Analyses, Cost-Minimization .
Analysis, Cost-Minimization .
Comparison, Cost .
Comparisons, Cost .
Cost Analyses .
Cost Comparisons .
Cost Measure .
Cost Minimization Analysis .
Cost, Cost Analysis .
Cost-Minimization Analyses .
Costs .
Measure, Cost .
Measures, Cost .
Absolute, comparative, or differential costs pertaining to services, institutions, resources, etc., or the analysis and study of these costs. .
0.67
 
Spectinomycin .
Adspec .
Ferkel Spectam .
Kempi .
Prospec .
Salmosan-T .
Spectam .
Spectinomycin Dihydrochloride, Anhydrous .
Spectinomycin Dihydrochloride, Pentahydrate .
Spectinomycin Hydrochloride .
Stanilo .
Trobicin .
Anhydrous Spectinomycin Dihydrochloride .
Salmosan T .
Spectam, Ferkel .
Actinospectacin .
An antibiotic produced by Streptomyces spectabilis. It is active against gram-negative bacteria and used for the treatment of GONORRHEA. .
0.60
 
Prion Proteins .
AltPrP .
Alternative Prion Protein .
CD230 Antigen .
Creutzfeldt-Jakob Disease Protein .
Fatal Familial Insomnia Protein .
Major Prion Protein .
Prion Protein .
Antigen, CD230 .
Creutzfeldt Jakob Disease Protein .
Prion Protein, Alternative .
Prion Protein, Major .
PrP Proteins .
Membrane glycosylphosphatidylinositol-anchored glycoproteins that may aggregate into rod-like structures. The prion protein (PRNP) gene is characterized by five TANDEM REPEAT SEQUENCES that encode a highly unstable protein region of five octapeptide repeats. Mutations in the repeat region and elsewhere in this gene are associated with CREUTZFELDT-JAKOB DISEASE; FATAL FAMILIAL INSOMNIA; GERSTMANN-STRAUSSLER DISEASE; Huntington disease-like 1, and KURU. .
0.53
 
Memory, Episodic .
Autobiographical Memory .
Memory, Prospective .
Prospective Memory .
Autobiographical Memories .
Episodic Memories .
Memories, Autobiographical .
Memories, Episodic .
Memories, Prospective .
Memory, Autobiographical .
Prospective Memories .
Episodic Memory .
Type of declarative memory, consisting of personal memory in contrast to general knowledge. .
0.52
 
Prospective Studies .
Prospective Study .
Studies, Prospective .
Study, Prospective .
Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. .
0.52